Objective: 
To discuss the opportunities and purposes of ClinLine – the new integrated infomedia platform for all parties involved in clinical trials, which could facilitate clinical trial search, site selection, patient recruitment, and improve transparency of clinical trial process in Russia.
Abstract Text:
The database for clinical trials, investigators and clinical sites was developed based on official MoH registers. The cross-searching functionality was implemented. The platform allows creating personal accounts/profiles for patients and investigators and facilitates prescreening and communication.
Results:
The platform was launched in July 2018. The functionality includes cross-searching of clinical trials, sites and investigators, registration and creating profiles of patients/healthy volunteers and investigators, authorization of investigators with access to patient registry, application/invitation to a clinical trial, chat between patients/healthy volunteers and investigators, rating of patients/healthy volunteers and investigators. The database is up-to-date and synchronized daily; it contains 6,040 trials including 2,604 ongoing studies, 3,859 investigators, and 1,434 accredited clinical sites. Top 10 indications for clinical trials in Russia include lung cancer, breast cancer, bronchial asthma, diabetes mellitus, rheumatoid arthritis, ulcerative colitis, infections (prophylaxis), lymphoma, multiple sclerosis, and flu. 137 investigators, 87 patients and 61 healthy volunteers registered within the first three months. The monthly web-site activity was approximately 13,000 page views with 5,000 individual visitors including over 20% visitors aged 45 year and older (6.0±0.3 minutes per visit). The platform was presented at several industry conferences and received positive feedback from representatives of clinical trial community. Further steps will include promotion among patient communities including internet and conferences, involvement of more investigators and development of functionality for Sponsors/CRO (i.e. site selection, analytics, etc.).
Conclusion:
Having a common platform for clinical trial participants will encourage more patients in drug development process, allow better access to clinical trials, streamline communication between patients and investigators, and provide the society with more transparency and understanding of drug research. Feasibility and pre-screening capabilities will improve the site selection process and minimize enrollment timelines. The platform also aims to attract more Sponsors to the Russian clinical trial market.

ClinLine.ru – the first Russian clinical trial platform for Patients, Investigators, Sponsors and CRO

DIA Europe 2019

A global, member-driven non-profit organization mobilizing life sciences and healthcare. DIA fosters innovation to improve health and well-being worldwide. Professionals from 80 countries continue to engage with DIA through our unparalleled membership network, educational offerings, and professional development opportunities.